Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Current Assets (2018 - 2025)

AVITA Medical's Current Assets history spans 8 years, with the latest figure at $35.5 million for Q4 2025.

  • For Q4 2025, Current Assets fell 37.74% year-over-year to $35.5 million; the TTM value through Dec 2025 reached $35.5 million, down 37.74%, while the annual FY2025 figure was $35.5 million, 37.74% down from the prior year.
  • Current Assets reached $35.5 million in Q4 2025 per RCEL's latest filing, down from $41.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $123.7 million in Q1 2021 to a low of $35.5 million in Q4 2025.
  • Average Current Assets over 5 years is $78.8 million, with a median of $84.4 million recorded in 2023.
  • Peak YoY movement for Current Assets: surged 54.78% in 2021, then crashed 50.31% in 2025.
  • A 5-year view of Current Assets shows it stood at $92.1 million in 2021, then fell by 5.07% to $87.5 million in 2022, then grew by 18.92% to $104.0 million in 2023, then plummeted by 45.2% to $57.0 million in 2024, then plummeted by 37.74% to $35.5 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Current Assets are $35.5 million (Q4 2025), $41.4 million (Q3 2025), and $36.3 million (Q2 2025).